These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8996197)

  • 1. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
    Kim PM; Winn LM; Parman T; Wells PG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts.
    Vienneau DS; DeBoni U; Wells PG
    Cancer Res; 1995 Mar; 55(5):1045-51. PubMed ID: 7866987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
    Kim PM; Wells PG
    Cancer Res; 1996 Apr; 56(7):1526-32. PubMed ID: 8603397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    Winn LM; Wells PG
    Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactions.
    Nakajima M; Yamanaka H; Fujiwara R; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Sep; 35(9):1679-86. PubMed ID: 17576806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
    Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
    Hu Z; Wells PG
    J Pharmacol Exp Ther; 1992 Oct; 263(1):334-42. PubMed ID: 1403794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of phenytoin metabolites, 5-(4'-hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases.
    Yamanaka H; Nakajima M; Hara Y; Katoh M; Tachibana O; Yamashita J; Yokoi T
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):135-43. PubMed ID: 15855726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
    Bhuller Y; Jeng W; Wells PG
    Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
    Hu Z; Wells PG
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):306-13. PubMed ID: 8048075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
    Liu L; Wells PG
    Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
    Narayanan R; LeDuc B; Williams DA
    Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport.
    Wong HY; Chu TS; Chan YW; Fok TF; Fung LW; Fung KP; Ho YY
    Life Sci; 2005 Mar; 76(16):1859-72. PubMed ID: 15698863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
    Ozolins TR; Wiley MJ; Wells PG
    Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.